Sandoz announces the extension and expansion of its strategic collaboration agreement with Ares Genetics (Ares), aimed at driving cutting-edge digital solutions in the global fight against antimicrobial resistance (AMR).
The extension of the existing master services agreement with Ares, a subisidiary of OpGen Inc, reflects both companies’ recognition of the critical importance of surveillance data to inform better prescribing and use of antibiotics – a central component of the global AMR response strategy.
[expert_review params=”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”]
During the initial stage of the collaboration, Ares developed a digital anti-infectives platform, combining established microbiology laboratory practices with advanced bioinformatics and AI methods to support the identification of effective antimicrobial compounds or compound combinations to address critical pathogens, which Sandoz can in turn leverage to drive portfolio and commercial decisions.
In the upcoming next phase, both collaboration parties intend to focus further on antibiotic stewardship by enabling genomic surveillance for resistant pathogens, using Ares’ next-generation sequencing (NGS) and bioinformatics technologies. Financial details are not being disclosed at this stage.
